Exhibit 24.1
SIGNATURES
Pursuant to the requirements of the Securities Act, the Registrant has duly caused this Form F-4 to be signed on its behalf by the undersigned, thereunto duly authorized, in Basel, Switzerland, on December 23 , 2010.
| Novartis AG | |
|
| |
| By: | /s/ Joseph Jimenez |
|
|
|
| Name: | Joseph Jimenez |
| Title: | Chief Executive Officer |
|
|
|
|
|
|
| By: | /s/ Jonathan Symonds |
|
|
|
| Name: | Jonathan Symonds |
| Title: | Chief Financial Officer |
Each person whose signature appears below hereby constitutes and appoints Jonathan Symonds, Thomas Werlen, Felix Senn, Andreas Bohrer, Marvelle Sullivan, Stefan Sulzer, Daniel Weiss and Peter Kerrane, jointly and severally, his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including pre-effective amendments and post-effective amendments) and supplements to this Registration Statement on Form F-4 (and any and all additional registration statements, including registration statements filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended), and to file the same, with all exhibits thereto, and other documents in connection therewith, with the SEC, granting unto each said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as they or he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them or their or his substitute or substitutes, may lawfully do or cause to be done by virtue thereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the dates indicated.
Signature |
| Title |
| Date |
|
|
|
|
|
/s/ Joseph Jimenez |
| Chief Executive Officer (principal executive officer) |
| December 23, 2010 |
Joseph Jimenez |
|
|
|
|
|
|
|
|
|
/s/ Jonathan Symonds |
| Chief Financial Officer (principal financial and accounting officer) |
| December 23, 2010 |
Jonathan Symonds |
| |||
|
|
|
|
|
/s/ Dr. Daniel Vasella |
| Chairman of the Board of Directors |
| December 23, 2010 |
Dr. Daniel Vasella |
|
|
|
|
|
|
|
|
|
/s/ Dr. Ulrich Lehner |
| Vice Chairman of the Board of Directors |
| December 23, 2010 |
Dr. Ulrich Lehner |
|
|
|
|
|
|
|
|
|
/s/ Hans-Jörg Rudloff |
| Vice Chairman of the Board of Directors |
| December 23, 2010 |
Hans-Jörg Rudloff |
|
|
|
|
Signature |
| Title |
| Date |
|
|
|
|
|
/s/ Dr. William Brody |
| Director |
| December 23, 2010 |
Dr. William Brody |
|
|
|
|
|
|
|
|
|
/s/ Srikant Datar, Ph.D. |
| Director |
| December 23, 2010 |
Srikant Datar, Ph.D. |
|
|
|
|
|
|
|
|
|
/s/ Ann Fudge |
| Director |
| December 23, 2010 |
Ann Fudge |
|
|
|
|
|
|
|
|
|
/s/ Alexandre F. Jetzer |
| Director |
| December 23, 2010 |
Alexandre F. Jetzer |
|
|
|
|
|
|
|
|
|
/s/ Pierre Landolt |
| Director |
| December 23, 2010 |
Pierre Landolt |
|
|
|
|
|
|
|
|
|
/s/ Dr. Andreas von Planta |
| Director |
| December 23, 2010 |
Dr. Andreas von Planta |
|
|
|
|
|
|
|
|
|
/s/ Dr. Ing. Wendelin Wiedeking |
| Director |
| December 23, 2010 |
Dr. Ing. Wendelin Wiedeking |
|
|
|
|
|
|
|
|
|
/s/ Marjorie M. Yang |
| Director |
| December 23, 2010 |
Marjorie M. Yang |
|
|
|
|
|
|
|
|
|
/s/ Dr. Rolf M. Zinkernagel |
| Director |
| December 23, 2010 |
Dr. Rolf M. Zinkernagel |
|
|
|
|
|
|
|
|
|
/s/ Barry Rosenfeld |
| Authorized US Representative |
| December 23, 2010 |
Barry Rosenfeld |
|
|
|
|